GemPharmatech Future Growth
Future criteria checks 5/6
GemPharmatech is forecast to grow earnings and revenue by 23.6% and 20.5% per annum respectively. EPS is expected to grow by 23.9% per annum. Return on equity is forecast to be 10.4% in 3 years.
Key information
23.6%
Earnings growth rate
23.9%
EPS growth rate
Life Sciences earnings growth | 27.3% |
Revenue growth rate | 20.5% |
Future return on equity | 10.4% |
Analyst coverage | Good |
Last updated | 24 Jun 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,125 | 309 | 139 | 369 | 4 |
12/31/2025 | 973 | 257 | 56 | 299 | 6 |
12/31/2024 | 773 | 205 | 60 | 240 | 4 |
3/31/2024 | 639 | 157 | -136 | 78 | N/A |
12/31/2023 | 622 | 159 | -89 | 117 | N/A |
9/30/2023 | 585 | 154 | -116 | 96 | N/A |
6/30/2023 | 562 | 161 | -107 | 110 | N/A |
3/31/2023 | 541 | 165 | -71 | 118 | N/A |
12/31/2022 | 517 | 165 | -84 | 106 | N/A |
9/30/2022 | 500 | 168 | -25 | 122 | N/A |
6/30/2022 | 466 | 160 | -16 | 125 | N/A |
3/31/2022 | 433 | 137 | -14 | 96 | N/A |
12/31/2021 | 394 | 125 | 24 | 113 | N/A |
12/31/2020 | 262 | 76 | -37 | 130 | N/A |
12/31/2019 | 193 | 30 | 19 | 65 | N/A |
12/31/2018 | 53 | -6 | 41 | 43 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688046's forecast earnings growth (23.6% per year) is above the savings rate (2.9%).
Earnings vs Market: 688046's earnings (23.6% per year) are forecast to grow faster than the CN market (22.1% per year).
High Growth Earnings: 688046's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688046's revenue (20.5% per year) is forecast to grow faster than the CN market (13.7% per year).
High Growth Revenue: 688046's revenue (20.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688046's Return on Equity is forecast to be low in 3 years time (10.4%).